Introduction
============

Superantigens are suspected of being potent initiators of Gram-positive sepsis, and new therapies for superantigen elimination are required. The effects of hemoadsorption with a superantigen-adsorbing device (SAAD) should be evaluated in septic swine. The aim of this study was to examine the efficacy of SAAD by sequential monitoring of physiological and serological parameters.

Methods
=======

Twelve landrace male pigs (25--38 kg) were mechanically ventilated and anesthetized with isofluorane. A Swan-Ganz catheter was inserted into the right jugular vein and the right carotid artery was used for the monitoring of blood pressure. The anti-toxic shock syndrome toxin-1 (anti-TSST-1) IgG antibody and anti-TSST-1 IgM antibody were under detection the level, as judged by ELISA. The LPS in the blood stream was also under the detection level (\<5 pg/ml). TSST-1 was infused at 2 μg/kg/hour, and the blood concentration was maintained at the clinical level for 6 hours, LPS (10 μg/kg/hours) was then infused to induce lethal shock. Heparin (200 U/kg/hour) was used as the anticoagulant. All animals were hemoperfused with SAAD or a control column for 8 hours and changes in pathological parameters and mortality were examined.

Results
=======

Animals perfused with SAAD had a highly significant (*P*\< 0.01) survival advantage compared with control groups at 24 hours after initiation of TSST-1 infusion. SAAD also suppressed the increase in the arterio-venous shunt ratio and decrease of partial arterial oxygen pressure at 6 hours after TSST-1 infusion initiation.

Conclusion
==========

We suggest that there is a potential application of SAAD in treating superantigen-induced respiratory dysfunction and sepsis.
